Also known as: LPL Gene Hyperlipoproteinemia Type 1 NGS Test, Familial Chylomicronemia Syndrome Genetic Test
Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3โ4 Weeks
LPL Gene Hyperlipoproteinemia Type 1 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
This advanced genetic diagnostic test is recommended for UAE residents to diagnose Type 1 Hyperlipoproteinemia with 99.9% accuracy. Services include ISO-certified VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection, with telephonic post-test guidance from a Consultant Medical Genetics.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection (daily 8 AM โ 11 PM).
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The LPL Gene Hyperlipoproteinemia Type 1 NGS Test employs Next-Generation Sequencing (NGS) to detect pathogenic variants in the LPL gene causing familial chylomicronemia syndrome and severe hypertriglyceridemia. In the UAE, this genetic analysis provides definitive diagnosis for suspected Type 1 hyperlipoproteinemia, enabling targeted lipid management and family cascade screening.
Our Test vs. Closest Alternative
| Feature | Our Test (NGS) | Standard Biochemical Lipid Panel |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity | Variable; indirect markers only |
| Method | Next-Generation Sequencing (NGS) full LPL gene coverage | Lipid profile (triglycerides, cholesterol subclasses) |
| Turnaround | 3โ4 Weeks | Same day |
| Clinical Utility | Confirms genetic cause, guides targeted therapy & family screening | Detection, not confirmation of aetiology |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I advise that a positive LPL gene result must be correlated with lipid profiles and family history. A negative result does not exclude other genetic or secondary causes of hypertriglyceridemia. Always integrate findings with comprehensive clinical evaluation," says Lina Osama Zaki Quteineh (DHA License: 9294403). This test supports but does not replace clinical judgment.
Clinical Advisory: Medication and Safety
Do not discontinue any prescribed lipid-lowering agents (fibrates, omega-3 concentrates, insulin) or other medications without consulting your physician. Genetic testing is part of a comprehensive care plan, not a standalone therapeutic directive. Continue all current therapies unless directed otherwise.
Exclusion Criteria & Safety Red Flags
- Recent acute pancreatitis or hospitalization โ stabilize first; test only upon physician clearance.
- Current use of fibrates, omega-3 concentrates, or insulin: continue as prescribed; do not alter dosage for testing.
- Emergency Red Flags: Seek immediate medical attention for severe abdominal pain, altered consciousness, eruptive xanthomas, or triglyceride levels persistently above 11.3 mmol/L (1000 mg/dL).
Patient FAQ & Clinical Guidance
1. What does the LPL Gene Hyperlipoproteinemia Type 1 NGS test diagnose?
This test detects pathogenic DNA variants in the LPL gene causing familial chylomicronemia syndrome, leading to extremely high triglycerides and increased risk of pancreatitis. It provides a definitive molecular diagnosis for appropriate clinical management.
2. How is the sample collected in the UAE?
We offer premium VIP Mobile Phlebotomy with temperature-controlled cold-chain logistics. A trained phlebotomist collects a small blood sample (EDTA tube or FTA card) from your home, ensuring minimal discomfort and specimen integrity.
3. Can asymptomatic individuals with a family history take this test?
Yes, presymptomatic genetic screening is recommended for individuals with a family history of severe hypertriglyceridemia or recurrent pancreatitis. Early detection enables lifestyle modifications and proactive medical surveillance.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic and personal data are encrypted, securely stored, and handled under DHA standards.
Clinical & Logistical Metadata
| Test Name | LPL Gene Hyperlipoproteinemia Type 1 NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) โ Full LPL gene coverage |
| ICD-10-CM Code | E78.3 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No specific fasting required", "Continue all prescribed medications unless directed otherwise by a physician"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians